- Home
- SSL vs PTCT Comparison
SSL vs PTCT Comparison
Compare SSL & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSL
- PTCT
- Stock Information
- Founded
- SSL 1950
- PTCT 1998
- Country
- SSL South Africa
- PTCT United States
- Employees
- SSL N/A
- PTCT N/A
- Industry
- SSL Oil & Gas Production
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- SSL Energy
- PTCT Health Care
- Exchange
- SSL Nasdaq
- PTCT Nasdaq
- Market Cap
- SSL 4.0B
- PTCT 5.3B
- IPO Year
- SSL N/A
- PTCT 2013
- Fundamental
- Price
- SSL $6.72
- PTCT $71.58
- Analyst Decision
- SSL
- PTCT Buy
- Analyst Count
- SSL 0
- PTCT 17
- Target Price
- SSL N/A
- PTCT $73.24
- AVG Volume (30 Days)
- SSL 1.3M
- PTCT 1.0M
- Earning Date
- SSL 01-01-0001
- PTCT 11-04-2025
- Dividend Yield
- SSL N/A
- PTCT N/A
- EPS Growth
- SSL N/A
- PTCT N/A
- EPS
- SSL 0.59
- PTCT 8.94
- Revenue
- SSL $14,028,282,389.00
- PTCT $1,779,150,000.00
- Revenue This Year
- SSL $1.50
- PTCT $119.02
- Revenue Next Year
- SSL $6.56
- PTCT N/A
- P/E Ratio
- SSL $10.91
- PTCT $8.03
- Revenue Growth
- SSL N/A
- PTCT 97.54
- 52 Week Low
- SSL $2.78
- PTCT $35.95
- 52 Week High
- SSL $7.25
- PTCT $73.98
- Technical
- Relative Strength Index (RSI)
- SSL 61.77
- PTCT 71.08
- Support Level
- SSL $6.13
- PTCT $66.10
- Resistance Level
- SSL $6.40
- PTCT $73.98
- Average True Range (ATR)
- SSL 0.17
- PTCT 2.58
- MACD
- SSL 0.07
- PTCT 0.10
- Stochastic Oscillator
- SSL 95.78
- PTCT 70.62
About SSL Sasol Ltd.
Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main businesses: the Southern Africa Energy & Chemicals business and the International Chemical business. It generates maximum revenue from the Southern Africa Energy & Chemicals business, which operates integrated value chains with feedstock sourced from the Mining and Gas operating segments. Geographically, the company generates the majority of its revenue from South Africa.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.